BSEBoard Meeting5d ago · 13 Oct 2026, 07:21 pm
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve inter-alia the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026
HealthCare Global Enterprises Ltd · 539787
✦ AI SummaryResults
HealthCare Global Enterprises Ltd has scheduled a board meeting on November 05, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2026.
Attachments (1)
📄pdf
Download →
aa33968c-0607-4fb6-bb42-c7a153264fe9.pdf
View document text
October 13, 2026
National Stock Exchange of India Limited, BSE Limited,
Compliance Department, Compliance Department,
Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers,
Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001,
Maharashtra, India Maharashtra, India
Dear Sir/Madam,
Subject : Intimation of the Meeting of Board of Directors of HealthCare Global
Enterprises Limited (“the Company”).
Stock Code : BSE – 539787, NSE – HCG
Reference : Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”)
We would like to inform you that a meeting of Board of Directors of the Company is scheduled to be
held on Thursday, November 05, 2026, to consider and approve inter-alia the Unaudited Financial
Results (both Standalone and Consolidated) of the Company for the quarter and half year ended
September 30, 2026 (“Financial Results”).
Further in accordance with the Company’s code of conduct framed in accordance with the SEBI
(Prohibition of Insider Trading) Regulations, 2015, and amendments made thereunder, the trading
window for dealing in shares of the Company is closed for all Designated Persons of the Company and
their immediate relatives from October 01, 2026, and shall remain closed up to 48 hours after the
declaration of the Financial Results.
The above information is also available on the website of the Company and can be accessed at:
https://www.hcgoncology.com/
You are requested to take the information on record.
Thanking You,
For HealthCare Global Enterprises Limited
Sunu Manuel
Company Secretary and Compliance Officer.
HealthCare Global Enterprises Limited
Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India
Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India
91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489
Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag